Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-010828
Filing Date
2020-02-04
Accepted
2020-02-04 18:41:15
Documents
1
Period of Report
2020-01-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv537617_4.html 4  
1 OWNERSHIP DOCUMENT tv537617_4.xml 4 8791
  Complete submission text file 0001104659-20-010828.txt   10651
Mailing Address 1 DEXCEL STREET OR AKIVA L3 30600000
Business Address
Oren Dan (Reporting) CIK: 0001636701 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37521 | Film No.: 20575560

Mailing Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512
Business Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512 97225864657
Intec Pharma Ltd. (Issuer) CIK: 0001638381 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 DEXCEL STREET OR AKIVA L3 3060000
Business Address 1 DEXCEL STREET OR AKIVA L3 3060000 97246364040
Dexcel Pharma Technologies Ltd. (Reporting) CIK: 0001720007 (see all company filings)

State of Incorp.: L3 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37521 | Film No.: 20575559